RTW INVESTMENTS, LP Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$1.4T
Holdings
40
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (40 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RCKTRocket Pharmaceuticals Inc | 14,969,744 | $289.4B | 20.88% | |
| 2 | RGNXRegenxbio Inc | 2,079,555 | $149.2B | 10.76% | |
| 3 | PTCTPtc Therapeutics Inc | 4,073,690 | $137.4B | 9.91% | |
| 4 | SRPTSarepta Therapeutics Inc | 978,551 | $129.3B | 9.33% | |
| 5 | ARWRArrowhead Pharmaceuticals In | 8,299,542 | $112.9B | 8.14% | |
| 6 | —Dicerna Pharmaceuticals Inc | 5,044,813 | $61.8B | 4.46% | |
| 7 | BMYBristol Myers Squibb Co | 903,672 | $50.0B | 3.61% | |
| 8 | LIVNLivanova PLC | 431,000 | $43.0B | 3.10% | |
| 9 | —La Jolla Pharmaceutical Co | 1,345,881 | $39.3B | 2.83% | |
| 10 | —Achillion Pharmaceuticals In | 13,541,997 | $38.3B | 2.76% | |
| 11 | I9DNArbutus Biopharma Corp | 5,165,499 | $37.7B | 2.72% | |
| 12 | ALNYAlnylam Pharmaceuticals Inc | 352,200 | $34.7B | 2.50% | |
| 13 | 3M4Masimo Corp | 249,543 | $24.4B | 1.76% | |
| 14 | SLDBSolid Biosciences Inc | 675,771 | $22.8B | 1.64% | |
| 15 | VCELVericel Corp | 2,217,916 | $21.5B | 1.55% | |
| 16 | AGENEURAgenus Inc | 9,375,451 | $21.3B | 1.53% | |
| 17 | —Qiagen NV | 529,385 | $19.1B | 1.38% | |
| 18 | QUREUniqure NV | 409,370 | $15.5B | 1.12% | |
| 19 | —Corium Intl Inc | 1,923,217 | $15.4B | 1.11% | |
| 20 | ILMNIllumina Inc | 49,658 | $13.9B | 1.00% | |
| 21 | —Myokardia Inc | 261,395 | $13.0B | 0.94% | |
| 22 | VRAYQViewray Inc | 1,474,156 | $10.2B | 0.74% | |
| 23 | —Polarityte Inc | 426,670 | $10.0B | 0.72% | |
| 24 | CDNACaredx Inc | 764,532 | $9.4B | 0.67% | |
| 25 | —Bovie Medical Corp | 2,082,137 | $9.1B | 0.65% | |
| 26 | ECORGBPElectrocore Inc | 505,000 | $8.3B | 0.60% | |
| 27 | —Nuvectra Corp | 383,030 | $7.9B | 0.57% | |
| 28 | —Viveve Med Inc | 2,861,023 | $7.8B | 0.56% | |
| 29 | —Odonate Therapeutics Inc | 276,368 | $6.1B | 0.44% | |
| 30 | STIMNeuronetics Inc | 190,000 | $5.1B | 0.36% | |
| 31 | FIXXEURHomology Medicines Inc | 226,431 | $4.6B | 0.33% | |
| 32 | NVAXNovavax Inc | 2,644,346 | $3.5B | 0.26% | |
| 33 | —Vivus Inc 4.5 05/01/2020 | 4,000,000 | $3.1B | 0.23% | |
| 34 | —Proteostasis Therapeutics In | 1,077,408 | $3.0B | 0.22% | |
| 35 | ARGXArgenx Se | 25,559 | $2.1B | 0.15% | |
| 36 | —Novus Therapeutics Inc | 301,799 | $2.1B | 0.15% | |
| 37 | —Tapimmune Inc | 200,000 | $1.9B | 0.14% | |
| 38 | —Bellicum Pharmaceuticals Inc | 150,289 | $1.1B | 0.08% | |
| 39 | ADVMCHFAdverum Biotechnologies Inc | 176,372 | $935.0M | 0.07% | |
| 40 | —Motus Gi Hldgs Inc | 59,478 | $428.0M | 0.03% |